Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of SYM024, SYM023, and SYM025 in Adults with Advanced Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Expression

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium France Hungary Italy Romania +1
  • Study on the Effects and Safety of Cemiplimab and BNT116 in Adults with Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Germany Poland Spain
  • Study of Tiragolumab, Atezolizumab, and Chemotherapy for Patients with Non-Small Cell Lung Cancer (NSCLC)

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia France Germany Greece +7
  • Study of Durvalumab with Chemoradiation Therapy for Patients with Unresectable, Locally Advanced Non-small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Hungary Poland
  • A study to evaluate how lazertinib is absorbed in healthy adults to support future treatment for non-small cell lung cancer.

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

    Not recruiting

    3 1 1
    Investigated drugs:
    Greece Poland Portugal Romania Spain
  • Study of alectinib, pemetrexed, carboplatin and cisplatin in patients with resectable stage I-III non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Austria Belgium Denmark France Italy The Netherlands +2
  • Comparison of Sotorasib versus Docetaxel in Previously Treated Non-Small Cell Lung Cancer Patients with KRAS p.

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Greece Italy The Netherlands Poland +2
  • Study of Sotorasib Alone and Combined with Pembrolizumab in Adult Patients with Advanced Solid Tumors Having KRAS p.

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Austria Belgium France Greece Hungary Portugal +2